Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2019
December 2019
164
About the Report
About the Report
Deep Brain Stimulators (DBS)-Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, Deep Brain Stimulators (DBS)-Medical Devices Pipeline Assessment, 2019" provides an overview of Deep Brain Stimulators (DBS) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators (DBS) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Deep Brain Stimulators (DBS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Deep Brain Stimulators (DBS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Deep Brain Stimulators (DBS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Products
Products
Adaptive Neuromodulation GmbH, CR-Capable Implant, Coordinated Reset Technology , Parkinson's Disease; Adept Neuro SA, Stereo-Electro-Encephalo-Graphie Electrode, Epilepsy; Aleva Neurotherapeutics SA, directSTIM, MicroDBS technology, Essential Tremor; Aleva Neurotherapeutics SA, directSTIM, MicroDBS technology, Parkinson's Disease; Baylor College of Medicine, Adaptive Deep Brain Stimulation (aDBS) Device, Essential Tremor; Baylor College of Medicine, Adaptive Deep Brain Stimulation (aDBS) Device, Obsessive Compulsive Disorder ; Baylor College of Medicine, Adaptive Deep Brain Stimulation (aDBS) Device, Parkinson's Disease; Baylor College of Medicine, Adaptive Deep Brain Stimulation (aDBS) Device, Tourette's Syndrome; Bioinduction Limited, Picostim, Hypertension; Bioinduction Limited, Picostim, Parkinson's Disease; Boston Scientific Corp, Enspire DBS Therapy System - Traumatic Brain Injury, Traumatic Brain Injury; Boston Scientific Corp, Next Generation DBS System, Neurological Disorders; Boston Scientific Corp, Vercise Deep Brain Stimulation System - Dystonia, Dystonia; Boston Scientific Corp, Vercise Deep Brain Stimulation System - Tremors, Tremor; Brainsway Ltd, Deep TMS System - Alzheimer's Disease, Transcranial Magnetic Stimulation Technology, Alzheimer's Disease; Brainsway Ltd, Deep TMS System - Bipolar Disorder, Transcranial Magnetic Stimulation Technology, Bipolar Disorder; Brainsway Ltd, Deep TMS System - PTSD, Transcranial Magnetic Stimulation Technology, Post-traumatic Stress Disorder; Brainsway Ltd, Deep TMS System - Smoking Cessation, Transcranial Magnetic Stimulation Technology; Brainsway Ltd, Deep Transcrainal Magnetic Stimulation Device - Opioid Use Disorder, Transcranial Magnetic Stimulation Technology, Opioid Use Disorder; Cleveland Medical Devices Inc, ParkinTune, Parkinson's Disease; Clinatec, Intracranial Deep Brain Stimulation Device, Parkinson's Disease; Cortera Neurotechnologies Inc, WAND, Epilepsy; Cortera Neurotechnologies Inc, WAND, Parkinson's Disease; Deep Brain Innovations, LLC, TOPS Device - Alzheimer's disease, Temporally Optimized Patterned Stimulation (TOPS) Technology, Alzheimer's Disease; Deep Brain Innovations, LLC, TOPS Device - Depression, Temporally Optimized Patterned Stimulation (TOPS) Technology, Depression; Deep Brain Innovations, LLC, TOPS Device - Epilepsy, Temporally Optimized Patterned Stimulation (TOPS) Technology, Epilepsy; Deep Brain Innovations, LLC, TOPS Device - Obesity, Temporally Optimized Patterned Stimulation (TOPS) Technology, Obesity; Deep Brain Innovations, LLC, TOPS Device - Obsessive-Compulsive Disorder, Temporally Optimized Patterned Stimulation (TOPS) Technology, Obsessive Compulsive Disorder ; Deep Brain Innovations, LLC, TOPS Device - Parkinson's disease, Temporally Optimized Patterned Stimulation (TOPS) Technology, Parkinson's Disease; Enspire DBS Therapy Inc, Enspire DBS Therapy System, Brain Stroke ; Functional Neuromodulation Inc., Deep Brain Stimulation Device - Dystonia, Deep Brain Stimulation (DBS) Technology, Dystonia; Functional Neuromodulation Inc., Deep Brain Stimulation Device - Mild Alzheimer's Disease, Deep Brain Stimulation (DBS) Technology, Alzheimer's Disease; Functional Neuromodulation Inc., Deep Brain Stimulation Device - OCD, Deep Brain Stimulation (DBS) Technology, Obsessive Compulsive Disorder ; Louisiana State University, Wireless Implantable Neural Stimulator, Pain; Massachusetts General Hospital, Deep Brain Stimulation Device, Depression; Massachusetts General Hospital, Deep Brain Stimulation Device, Post-traumatic Stress Disorder; Massachusetts General Hospital, Deep Brain Stimulation Device, Traumatic Brain Injury; Massachusetts General Hospital, Deep Brain Stimulation System, Resistive Tapered Stripline (RTS) Technology, Epilepsy; Massachusetts General Hospital, Deep Brain Stimulation System, Resistive Tapered Stripline (RTS) Technology, Parkinson's Disease; Massachusetts General Hospital, Deep Brain Stimulation System, Resistive Tapered Stripline (RTS) Technology, Stroke; Massachusetts Institute of Technology, Implantable Micro - Cannula Device, Alzheimer's Disease; Massachusetts Institute of Technology, Implantable Micro - Cannula Device, Anxiety; Massachusetts Institute of Technology, Implantable Micro - Cannula Device, Mood Disorders; Massachusetts Institute of Technology, Implantable Micro - Cannula Device, Parkinson's Disease; Medtronic plc, Cranial Mounted DBS, Neurological Disorders; Medtronic plc, DBS Primary Cell Device, Neurological Disorders; Medtronic plc, Percept PC DBS - Passive Sensing, Neurological Disorders; Medtronic plc, Reclaim Deep Brain Stimulation System - Depression, Deep Brain Stimulation (DBS) Technology, Depression; Medtronic plc, Sapiens DBS Field Steering System, Neurological Disorders; Medtronic plc, Sapiens DBS Field Steering System, Parkinson's Disease; National Cheng-Kung University Hospital, Responsive Epilepsy Control System-On-Chip, Epilepsy; NeuroOne Inc, Deep Brain Stimulation System, Dystonia; NeuroOne Inc, Deep Brain Stimulation System, Epilepsy; NeuroOne Inc, Deep Brain Stimulation System, Essential Tremor; NeuroOne Inc, Deep Brain Stimulation System, Parkinson's Disease; Neuroparticle Corp, Non-Invasive Deep Brain Stimulation Device, Drug Abuse; NeuroPro Technologies Inc, Deep Brain Stimulation, Depression; NeuroPro Technologies Inc, Deep Brain Stimulation, Dystonia; NeuroPro Technologies Inc, Deep Brain Stimulation, Parkinson's Disease; NeuroPro Technologies Inc, Deep Brain Stimulation, Tremor; Neurosigma Inc, Deep Brain Stimulation System - Cachexia, Cachexia; Neurosigma Inc, Deep Brain Stimulation System - Obesity, Obesity; Newronika s.r.l., AlphaDBS, Parkinson's Disease; Nexeon MedSystems Inc, Synapse, Parkinson's Disease; Nexeon MedSystems Inc, Viant Deep Brain Stimulation System, Dystonia; Nexeon MedSystems Inc, Viant Deep Brain Stimulation System, Essential Tremor; Nexeon MedSystems Inc, Viant Deep Brain Stimulation System, Parkinson's Disease; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Indigenous Deep Brain Stimulation Device, Dystonia; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Indigenous Deep Brain Stimulation Device, Essential Tremor; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Indigenous Deep Brain Stimulation Device, Parkinson's Disease; St. Jude Medical LLC, Libra Deep Brain Stimulation System - Depression, Major Depressive Disorder; St. Jude Medical LLC, Next Generation Implantable DBS System - Primary Cell, Neurological Disorders; Sunnybrook Health Sciences Centre, Deep Brain Stimulation Device - PTSD, Post-Traumatic Stress Disorder (PTSD); SUNY Downstate Medical Center, Low-Frequency Sine Wave Neurostimulation Therapy Device, Epilepsy; University of California Los Angeles, Implantable Ultrasound Neuromodulation Device, Neurological Disorders; University of California Los Angeles, Wireless Deep Brain Stimulating System, Traumatic Brain Injury; University of Central Florida, Deep Brain Stimulation System, Epilepsy; University of Central Florida, Deep Brain Stimulation System, Parkinson's Disease; University of Central Florida, Deep Brain Stimulation System, Tourette's Syndrome; University of Florida, Closed-Loop Deep Brain Stimulation System, Essential Tremor; University of Florida, Deep Brain Stimulation System, Movement Disorders; University of Houston, Closed-Loop Brain Stimulator - PTSD, Post-Traumatic Stress Disorder (PTSD); University of Illinois, Wireless Deep Brain Stimulation System - Essential Tremor, Essential Tremor; University of Milan, Implantable Brain Pacemaker, Parkinson's Disease; University of Minnesota, Two-Shank Auditory Midbrain Implant, Hearing Impairment; University of Oxford, Adaptive Deep Brain Stimulation System, Parkinson's Disease; University of Rochester, Deep Brain Magnetic Stimulator, Alzheimer's Disease; University of Rochester, Deep Brain Magnetic Stimulator, Multiple Sclerosis; University of Rochester, Deep Brain Magnetic Stimulator, Parkinson's Disease; University of Rochester, Deep Brain Magnetic Stimulator, Spinal Trauma; University of South Florida, Deep Brain Stimulator, Neurological Disorders; Wedge Therapeutics, SONS System, Alzheimer's Disease
Companies
Adaptive Neuromodulation GmbH
Adept Neuro SA
Aleva Neurotherapeutics SA
Baylor College of Medicine
Bioinduction Limited
Boston Scientific Corp
Brainsway Ltd
Cleveland Medical Devices Inc
Clinatec
Cortera Neurotechnologies Inc
Deep Brain Innovations, LLC
Enspire DBS Therapy Inc
Functional Neuromodulation Inc.
Louisiana State University
Massachusetts General Hospital
Massachusetts Institute of Technology
Medtronic plc
National Cheng-Kung University Hospital
NeuroOne Inc
Neuroparticle Corp
NeuroPro Technologies Inc
Neurosigma Inc
Newronika s.r.l.
Nexeon MedSystems Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Sunnybrook Health Sciences Centre
SUNY Downstate Medical Center
University of California Los Angeles
University of Central Florida
University of Florida
University of Houston
University of Illinois
University of Milan
University of Minnesota
University of Oxford
University of Rochester
University of South Florida
Wedge Therapeutics
Table of Contents
Table of Contents
Table of Contents
1.1 List of Tables 6
1.2 List of Figures 10
2 Introduction 11
2.1 Deep Brain Stimulators (DBS) Overview 11
3 Products under Development 12
3.1 Deep Brain Stimulators (DBS)-Pipeline Products by Stage of Development 12
3.2 Deep Brain Stimulators (DBS)-Pipeline Products by Territory 13
3.3 Deep Brain Stimulators (DBS)-Pipeline Products by Regulatory Path 14
3.4 Deep Brain Stimulators (DBS)-Pipeline Products by Estimated Approval Date 15
3.5 Deep Brain Stimulators (DBS)-Ongoing Clinical Trials 16
4 Deep Brain Stimulators (DBS)-Pipeline Products under Development by Companies 17
4.1 Deep Brain Stimulators (DBS) Companies-Pipeline Products by Stage of Development 17
4.2 Deep Brain Stimulators (DBS)-Pipeline Products by Stage of Development 19
5 Deep Brain Stimulators (DBS) Companies and Product Overview 21
5.1 Adaptive Neuromodulation GmbH Company Overview 21
5.1.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
5.2 Adept Neuro SA Company Overview 22
5.2.1 Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 Aleva Neurotherapeutics SA Company Overview 23
5.3.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 Baylor College of Medicine Company Overview 24
5.4.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Bioinduction Limited Company Overview 25
5.5.1 Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 Boston Scientific Corp Company Overview 28
5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 Brainsway Ltd Company Overview 34
5.7.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
5.8 Cleveland Medical Devices Inc Company Overview 41
5.8.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.9 Clinatec Company Overview 42
5.9.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview 42
5.10 Cortera Neurotechnologies Inc Company Overview 43
5.10.1 Cortera Neurotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43
5.11 Deep Brain Innovations, LLC Company Overview 44
5.11.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 44
5.12 Enspire DBS Therapy Inc Company Overview 49
5.12.1 Enspire DBS Therapy Inc Pipeline Products & Ongoing Clinical Trials Overview 49
5.13 Functional Neuromodulation Inc. Company Overview 52
5.13.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.14 Louisiana State University Company Overview 57
5.14.1 Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview 57
5.15 Massachusetts General Hospital Company Overview 58
5.15.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 58
5.16 Massachusetts Institute of Technology Company Overview 60
5.16.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 60
5.17 Medtronic plc Company Overview 61
5.17.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 61
5.18 National Cheng-Kung University Hospital Company Overview 65
5.18.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 65
5.19 NeuroOne Inc Company Overview 66
5.19.1 NeuroOne Inc Pipeline Products & Ongoing Clinical Trials Overview 66
5.20 Neuroparticle Corp Company Overview 67
5.20.1 Neuroparticle Corp Pipeline Products & Ongoing Clinical Trials Overview 67
5.21 NeuroPro Technologies Inc Company Overview 68
5.21.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 68
5.22 Neurosigma Inc Company Overview 69
5.22.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.23 Newronika s.r.l. Company Overview 71
5.23.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 71
5.24 Nexeon MedSystems Inc Company Overview 74
5.24.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 74
5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 76
5.25.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 76
5.26 St. Jude Medical LLC Company Overview 77
5.26.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 77
5.27 Sunnybrook Health Sciences Centre Company Overview 82
5.27.1 Sunnybrook Health Sciences Centre Pipeline Products & Ongoing Clinical Trials Overview 82
5.28 SUNY Downstate Medical Center Company Overview 85
5.28.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 85
5.29 University of California Los Angeles Company Overview 86
5.29.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 86
5.30 University of Central Florida Company Overview 88
5.30.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 88
5.31 University of Florida Company Overview 89
5.31.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 89
5.32 University of Houston Company Overview 91
5.32.1 University of Houston Pipeline Products & Ongoing Clinical Trials Overview 91
5.33 University of Illinois Company Overview 92
5.33.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 92
5.34 University of Milan Company Overview 93
5.34.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview 93
5.35 University of Minnesota Company Overview 94
5.35.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 94
5.36 University of Oxford Company Overview 95
5.36.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 95
5.37 University of Rochester Company Overview 96
5.37.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 96
5.38 University of South Florida Company Overview 97
5.38.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 97
5.39 Wedge Therapeutics Company Overview 98
5.39.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 98
6 Deep Brain Stimulators (DBS)- Recent Developments 99
6.1 Nov 25, 2019: BrainsWay reports third quarter 2019 financial results and operational highlights 99
6.2 Nov 25, 2019: BrainsWay appoints Medical Technology Industry Leader Christopher R. von Jako, Ph.D., as President and Chief Executive Officer 100
6.3 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 101
6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 103
6.5 Nov 12, 2019: TMS program hosts open house to introduce Deep Transcranial Magnetic Stimulation (Deep TMS) Helmet to treat major depressive disorder (MDD) and Obsessive-Compulsive Disorder (OCD) 104
7 Appendix 161
7.1 Methodology 161
7.2 About GlobalData 164
7.3 Contact Us 164
7.4 Disclaimer 164
List of Figure
List of Figures
Figure 1: Deep Brain Stimulators (DBS)-Pipeline Products by Stage of Development
Figure 2: Deep Brain Stimulators (DBS)-Pipeline Products by Territory
Figure 3: Deep Brain Stimulators (DBS)-Pipeline Products by Regulatory Path
Figure 4: Deep Brain Stimulators (DBS)-Pipeline Products by Estimated Approval Date
Figure 5: Deep Brain Stimulators (DBS)-Ongoing Clinical Trials
List of Table
List of Tables
Table 1: Deep Brain Stimulators (DBS)-Pipeline Products by Stage of Development
Table 2: Deep Brain Stimulators (DBS)-Pipeline Products by Territory
Table 3: Deep Brain Stimulators (DBS)-Pipeline Products by Regulatory Path
Table 4: Deep Brain Stimulators (DBS)-Pipeline Products by Estimated Approval Date
Table 5: Deep Brain Stimulators (DBS)-Ongoing Clinical Trials
Table 6: Deep Brain Stimulators (DBS) Companies-Pipeline Products by Stage of Development
Table 7: Deep Brain Stimulators (DBS)-Pipeline Products by Stage of Development
Table 8: Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 9: CR-Capable Implant-Product Status
Table 10: CR-Capable Implant-Product Description
Table 11: Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Stereo-Electro-Encephalo-Graphie Electrode-Product Status
Table 13: Stereo-Electro-Encephalo-Graphie Electrode-Product Description
Table 14: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
Table 15: directSTIM-Product Status
Table 16: directSTIM-Product Description
Table 17: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Adaptive Deep Brain Stimulation (aDBS) Device-Product Status
Table 19: Adaptive Deep Brain Stimulation (aDBS) Device-Product Description
Table 20: Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Picostim-Product Status
Table 22: Picostim-Product Description
Table 23: Bioinduction Limited-Ongoing Clinical Trials Overview
Table 24: Picostim-Simpler and Safer Deep Brain Stimulation for Parkinson's Disease
Table 25: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Enspire DBS Therapy System-Traumatic Brain Injury-Product Status
Table 27: Enspire DBS Therapy System-Traumatic Brain Injury-Product Description
Table 28: Next Generation DBS System-Product Status
Table 29: Next Generation DBS System-Product Description
Table 30: Vercise Deep Brain Stimulation System-Dystonia-Product Status
Table 31: Vercise Deep Brain Stimulation System-Dystonia-Product Description
Table 32: Vercise Deep Brain Stimulation System-Tremors-Product Status
Table 33: Vercise Deep Brain Stimulation System-Tremors-Product Description
Table 34: Boston Scientific Corp-Ongoing Clinical Trials Overview
Table 35: Vercise Deep Brain Stimulation System-Dystonia-Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Table 36: Vercise Deep Brain Stimulation System-Dystonia-Registry of Deep Brain Stimulation with the Vercise System for Treatment of Dystonia: Vercise DBS Dystonia Registry
Table 37: Vercise Deep Brain Stimulation System-Dystonia-Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology
Table 38: Vercise Deep Brain Stimulation System-Tremors-Boston Scientific Registry of Deep Brain Stimulations for Treatment of Essential Tremor (ET): ET Registry
Table 39: Vercise Deep Brain Stimulation System-Tremors-Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Table 40: Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Deep TMS System-Alzheimer's Disease-Product Status
Table 42: Deep TMS System-Alzheimer's Disease-Product Description
Table 43: Deep TMS System-Bipolar Disorder-Product Status
Table 44: Deep TMS System-Bipolar Disorder-Product Description
Table 45: Deep TMS System-PTSD-Product Status
Table 46: Deep TMS System-PTSD-Product Description
Table 47: Deep TMS System-Smoking Cessation-Product Status
Table 48: Deep TMS System-Smoking Cessation-Product Description
Table 49: Deep Transcrainal Magnetic Stimulation Device-Opioid Use Disorder-Product Status
Table 50: Deep Transcrainal Magnetic Stimulation Device-Opioid Use Disorder-Product Description
Table 51: Brainsway Ltd-Ongoing Clinical Trials Overview
Table 52: Deep TMS System-Bipolar Disorder-A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation (TMS) in Conjunction with Mood Stabilizers in Subjects with Bipolar Depression
Table 53: Deep TMS System-PTSD-A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation (DTMS) System for the Treatment of Post-traumatic Stress Disorder (PTSD)
Table 54: Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: ParkinTune-Product Status
Table 56: ParkinTune-Product Description
Table 57: Clinatec Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Intracranial Deep Brain Stimulation Device-Product Status
Table 59: Intracranial Deep Brain Stimulation Device-Product Description
Table 60: Cortera Neurotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: WAND-Product Status
Table 62: WAND-Product Description
Table 63: Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 64: TOPS Device-Alzheimer's disease-Product Status
Table 65: TOPS Device-Alzheimer's disease-Product Description
Table 66: TOPS Device-Depression-Product Status
Table 67: TOPS Device-Depression-Product Description
Table 68: TOPS Device-Epilepsy-Product Status
Table 69: TOPS Device-Epilepsy-Product Description
Table 70: TOPS Device-Obesity-Product Status
Table 71: TOPS Device-Obesity-Product Description
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.